FDA Takes a Baby Step on Factory Farm Antibiotics

<a href="http://www.flickr.com/photos/ciwf/3218274686/">Compassion in World Farming</a>/Flickr

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


For a few months now, President Obama’s FDA has been showing zero appetite for standing up to the meat industry on factory-farm livestock use. In two key decisions (here and here), the agency declined to impose real restrictions on farm drug use, promoting a “voluntary” approach instead.

But today, the FDA abruptly canned the lapdog shtick and growled like a real watchdog: It banned certain uses of the cephalosporin family of antibiotics. The FDA declared in a press release:

Cephalosporins are commonly used in humans to treat pneumonia as well as to treat skin and soft tissue infections. In addition, they are used in the treatment of pelvic inflammatory disease, diabetic foot infections, and urinary tract infections. If cephalosporins are not effective in treating these diseases, doctors may have to use drugs that are not as effective or that have greater side effects.  

Citing concern that routine use on factory farms will push pathogens to develop resistance to these antibiotics, the FDA has banned certain uses of them. Now before I show just how limited this move is in the grand scheme, I have to stress its historical significance. For 34 years, the agency has been wringing its hands over the dangers of farm antibiotic abuse, all the while doing precisely nothing about it (save for appointing committees and issuing polite requests for “judicious” use). Now it’s actually regulating. The Pew Campaign on Human Health and Industrial Farms, which advocates a ban on routine antibiotic use, praised the move Wednesday as an “important first step” in addressing the problem.

But make no mistake: This is just a first step, and nothing more. It turns out that cephalosporins make up a tiny—and shrinking—percentage of the antibiotics used in factory farms. This 2010 post from Ralph Loglisci Ralph Loglisci, Center for a Liveable FutureGraphic: Center for a Livable Future of the Johns Hopkins Center for a Liveable Future (h/t Helena Bottemiller) offers the chart to the right listing the amounts of various antibiotic families used on factory farms in 2009.

Note that these operations used 91,113 pounds of cephalosporins—an amount that literally rounds to zero compared to the whopping total of 28.8 million pounds they burn through. By comparison, they consumed more than 10 million pounds of tetracycline, also an extremely important drug for humans.

Now check out the FDA’s 2010 numbers (the latest that have been released) on livestock antibiotic use. The following chart compares 2009 and 2010 FDA data.

Note that the industry’s already-modest use of cephalosporin plunged 41 percent between 2009 and 2010. Meanwhile, overall antibiotic use held steady (rising 1 percent), tetracycline use jumped 21 percent, and consumption of penicillin—another important medicine you may have heard of—soared 43 percent to 1.9 million pounds.

Precisely why the industry is ramping up use of these two particular drugs is something I’ll be investigating. At first glance, what I’m getting from these numbers is that the FDA has courageously restricted the use of a drug the industry barely uses and is already phasing out, and it is cravenly looking the other way as the industry increasingly leans on other antibiotics as a crutch to prop up a reckless production system. Indeed, as Wired’s excellent Maryn McKenna points out, penicillin and tetracycline are in the very antibiotic families the FDA recently decided not to regulate.

We’ll know whether the agency is changing its ways if, in the coming year, it follows Wednesday’s ban with ones on drugs the industry is actually abusing. If not, then what we just heard from the FDA isn’t much more than the growl of a toothless watchdog.

AN IMPORTANT UPDATE ON MOTHER JONES' FINANCES

We need to start being more upfront about how hard it is keeping a newsroom like Mother Jones afloat these days.

Because it is, and because we're fresh off finishing a fiscal year, on June 30, that came up a bit short of where we needed to be. And this next one simply has to be a year of growth—particularly for donations from online readers to help counter the brutal economics of journalism right now.

Straight up: We need this pitch, what you're reading right now, to start earning significantly more donations than normal. We need people who care enough about Mother Jones’ journalism to be reading a blurb like this to decide to pitch in and support it if you can right now.

Urgent, for sure. But it's not all doom and gloom!

Because over the challenging last year, and thanks to feedback from readers, we've started to see a better way to go about asking you to support our work: Level-headedly communicating the urgency of hitting our fundraising goals, being transparent about our finances, challenges, and opportunities, and explaining how being funded primarily by donations big and small, from ordinary (and extraordinary!) people like you, is the thing that lets us do the type of journalism you look to Mother Jones for—that is so very much needed right now.

And it's really been resonating with folks! Thankfully. Because corporations, powerful people with deep pockets, and market forces will never sustain the type of journalism Mother Jones exists to do. Only people like you will.

There's more about our finances in "News Never Pays," or "It's Not a Crisis. This Is the New Normal," and we'll have details about the year ahead for you soon. But we already know this: The fundraising for our next deadline, $350,000 by the time September 30 rolls around, has to start now, and it has to be stronger than normal so that we don't fall behind and risk coming up short again.

Please consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

—Monika Bauerlein, CEO, and Brian Hiatt, Online Membership Director

payment methods

AN IMPORTANT UPDATE ON MOTHER JONES' FINANCES

We need to start being more upfront about how hard it is keeping a newsroom like Mother Jones afloat these days.

Because it is, and because we're fresh off finishing a fiscal year, on June 30, that came up a bit short of where we needed to be. And this next one simply has to be a year of growth—particularly for donations from online readers to help counter the brutal economics of journalism right now.

Straight up: We need this pitch, what you're reading right now, to start earning significantly more donations than normal. We need people who care enough about Mother Jones’ journalism to be reading a blurb like this to decide to pitch in and support it if you can right now.

Urgent, for sure. But it's not all doom and gloom!

Because over the challenging last year, and thanks to feedback from readers, we've started to see a better way to go about asking you to support our work: Level-headedly communicating the urgency of hitting our fundraising goals, being transparent about our finances, challenges, and opportunities, and explaining how being funded primarily by donations big and small, from ordinary (and extraordinary!) people like you, is the thing that lets us do the type of journalism you look to Mother Jones for—that is so very much needed right now.

And it's really been resonating with folks! Thankfully. Because corporations, powerful people with deep pockets, and market forces will never sustain the type of journalism Mother Jones exists to do. Only people like you will.

There's more about our finances in "News Never Pays," or "It's Not a Crisis. This Is the New Normal," and we'll have details about the year ahead for you soon. But we already know this: The fundraising for our next deadline, $350,000 by the time September 30 rolls around, has to start now, and it has to be stronger than normal so that we don't fall behind and risk coming up short again.

Please consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

—Monika Bauerlein, CEO, and Brian Hiatt, Online Membership Director

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate